FR2000114A1 - Solution aqueuse stable injectable de glucagon,et procede pour sa preparation - Google Patents

Solution aqueuse stable injectable de glucagon,et procede pour sa preparation

Info

Publication number
FR2000114A1
FR2000114A1 FR6900222A FR6900222A FR2000114A1 FR 2000114 A1 FR2000114 A1 FR 2000114A1 FR 6900222 A FR6900222 A FR 6900222A FR 6900222 A FR6900222 A FR 6900222A FR 2000114 A1 FR2000114 A1 FR 2000114A1
Authority
FR
France
Prior art keywords
glucagon
injection
preparation
aqueous solution
stable aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6900222A
Other languages
English (en)
French (fr)
Inventor
Jan Markussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Terapeutisk Laboratorium AS
Original Assignee
Novo Terapeutisk Laboratorium AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Terapeutisk Laboratorium AS filed Critical Novo Terapeutisk Laboratorium AS
Publication of FR2000114A1 publication Critical patent/FR2000114A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
FR6900222A 1968-01-10 1969-01-09 Solution aqueuse stable injectable de glucagon,et procede pour sa preparation Withdrawn FR2000114A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0536/68A GB1202607A (en) 1968-01-10 1968-01-10 Improvements in or relating to stable glucagon solutions and their preparation

Publications (1)

Publication Number Publication Date
FR2000114A1 true FR2000114A1 (fr) 1969-08-29

Family

ID=9723689

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6900222A Withdrawn FR2000114A1 (fr) 1968-01-10 1969-01-09 Solution aqueuse stable injectable de glucagon,et procede pour sa preparation

Country Status (7)

Country Link
AT (1) AT283600B (en))
BE (1) BE726681A (en))
DE (1) DE1900367A1 (en))
FR (1) FR2000114A1 (en))
GB (1) GB1202607A (en))
IT (1) IT974528B (en))
NL (1) NL6900460A (en))

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US7235627B2 (en) 1996-08-30 2007-06-26 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6458924B2 (en) 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
DE69918070T2 (de) * 1998-03-13 2005-08-25 Novo Nordisk A/S Stabilisierte, wässrige Glukagonlösungen, enthaltend Detergenzien
EP1061947B1 (en) * 1998-03-13 2004-06-16 Novo Nordisk A/S Stabilized aqueous glucagon solutions comprising detergents
EP2490708B1 (en) 2009-10-22 2013-03-27 Biodel Inc. Stabilized glucagon solutions
US9610329B2 (en) 2009-10-22 2017-04-04 Albireo Pharma, Inc. Stabilized glucagon solutions
WO2012059764A1 (en) 2010-11-03 2012-05-10 Arecor Limited Novel composition comprising glucagon
US9198971B2 (en) 2012-01-09 2015-12-01 Adocia Injectable solution at pH 7 comprising at least one basal insulin the pI of which is between 5.8 and 8.5 and a substituted co-polyamino acid
US20150314003A2 (en) 2012-08-09 2015-11-05 Adocia Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer
FR3052071B1 (fr) * 2016-06-07 2018-09-07 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon et un co-polyaminoacide
MX2018015070A (es) * 2016-06-07 2019-05-09 Adocia Composiciones en forma de solucion acuosa inyectable, que comprende glucagon humano y un co-poliaminoacido injertado en el extremo.
FR3061660B1 (fr) * 2017-01-10 2019-05-31 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
GB201611077D0 (en) 2016-06-24 2016-08-10 Arecor Ltd Novel composition
FR3074683B1 (fr) * 2017-12-07 2020-01-10 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
EP3720471B1 (fr) 2017-12-07 2023-11-29 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
FR3083087A1 (fr) 2018-06-29 2020-01-03 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
WO2019110838A1 (fr) 2017-12-07 2019-06-13 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
MA51018A (fr) 2017-12-07 2020-10-14 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
WO2019110836A1 (fr) 2017-12-07 2019-06-13 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
FR3067247A1 (fr) 2018-06-07 2018-12-14 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2643967A (en) * 1946-08-31 1953-06-30 Wallerstein Co Inc Concentrate of tyrothricin and its therapeutically active components
NL94376C (nl) * 1958-04-28 1960-05-16 Nv Organon Werkwijze ter bereiding van injicieerbare glacagonpreparaten met verlengde werking

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2643967A (en) * 1946-08-31 1953-06-30 Wallerstein Co Inc Concentrate of tyrothricin and its therapeutically active components
NL94376C (nl) * 1958-04-28 1960-05-16 Nv Organon Werkwijze ter bereiding van injicieerbare glacagonpreparaten met verlengde werking

Also Published As

Publication number Publication date
AT283600B (de) 1970-08-10
BE726681A (en)) 1969-07-09
NL6900460A (en)) 1969-07-14
DE1900367A1 (de) 1969-09-04
IT974528B (it) 1974-07-10
GB1202607A (en) 1970-08-19

Similar Documents

Publication Publication Date Title
FR2000114A1 (fr) Solution aqueuse stable injectable de glucagon,et procede pour sa preparation
DK128766B (da) Injektionssprøjte med to koaksiale, cylindriske kamre.
BE736070A (fr) Procédé de déshydratation d'aralcanols
ZA704419B (en) Injectable aqueous solutions of tetramisole
FI52459C (fi) Menetelmä antibakteeristen linkomysiinin tai sen johdannaisten 2-fosfa attien ja niiden suolojen valmistamiseksi.
CH516500A (fr) Procédé pour séparer, par estérification et extraction, des acides organiques contenus dans une solution aqueuse
BE773659A (fr) Solutions-meres acides, stables et concentrees de colorants anioniques et procede pour leur preparation
OA03109A (fr) Nouvelles pyrimidines et procédé pour leur préparation.
FR2002873A1 (fr) Nouveaux derives thiofeniques et procede pour leur preparation
BE775668A (fr) Solution stable de lactone et son procede de preparation
BG18624A3 (bg) Мултипреса за дехидратизация на листови продукти
BE755713A (fr) Leucoderives stabilises ameliores et procede perfectionne pour les produire
BE771735A (fr) 8-cyano-5-octanolide et procede pour sa preparation
OA03889A (fr) Procédé de préparation de benzamides hétérocycliques nouveaux.
BR6912416D0 (pt) Processo de preparacao de compostos macromoleculares
BE772187A (fr) Melanges de colloides et leur procede de preparation
BE816496A (fr) 6-(1-aminocyclohexanecarboxamido)penicillanate de sodium cristalin et procede de preparation
FR2002212A1 (fr) Derives de la l-amino-anthraquinone et leur procede de preparation
BE764509A (fr) Derives de dicycloalkane optiquement actifs et leur procede de preparation
BE746549A (fr) Nouvel oestratriol et procede pour sa preparation
BE750811A (fr) Suspension pharmaceutique aqueuse stabilisee
FI46722C (fi) Menetelmä 1alfa-hydroksi-18-metyyli-5alfa-H-androstaanijohdannaisten v almistamiseksi.
BE771036A (fr) Procede de preparation de composes azoiques et leur utilisationen teinture
OA03005A (fr) Nouvelles pyrimidines et procédé pour les préparer.
OA03603A (fr) Nouvel acide carboxylique et procédé pour sa préparation.

Legal Events

Date Code Title Description
ST Notification of lapse